Press What’s news at AbelsonTaylor Group
Select category
Cybersecurity considerations in pharma marketing: Trust must come first
“Responsible AI adoption is essential to protecting our clients, our agency, and the patients ultimately served by the work we help bring to life,” writes AbelsonTaylor Group’s Amer Ghafari, vice president of IT operations, in MedAdNews.
Read his thoughts on maintaining trust in pharmaceutical advertising with effective cybersecurity: https://www.pharmalive.com/cybersecurity-considerations-in-pharma-marketing-trust-must-come-first/
Media Contact:
Recent Posts
From Insights to Action: The Bridge Between Strategy and Execution
“Having access to more information doesn’t automatically lead to better decisions—you need judgment,” says AbelsonTaylor Group’s Amy Restko, VP, Engagement...
In the News Read more From Insights to Action: The Bridge Between Strategy and ExecutionRob Chartier Joins AbelsonTaylor Group as Director of Engagement Strategy
AbelsonTaylor Group today announced that Rob Chartier has joined the agency as Director of Engagement Strategy. Chartier brings more than...
Read Press Read more Rob Chartier Joins AbelsonTaylor Group as Director of Engagement StrategyThe Human Story Underneath the Data: Translating Clinical Rigor into Brand Strategy
In an interivew with Roastbrief US, Planning Director Elise Pietracatella explains how at AbelsonTaylor Group believes the science and the...
In the News Read more The Human Story Underneath the Data: Translating Clinical Rigor into Brand StrategyConnect with us
Find out what's top of mind for the people reimagining health and wellness advertising.